Role of matrix metalloproteinase-2/9 (MMP2/9) in lead-induced changes in an in vitro blood-brain barrier model

Medicine & Life Sciences

• Matrix Metalloproteinase 2 76%
• Matrix Metalloproteinase 9 75%
• Blood-Brain Barrier 67%
• Lead 63%
• Tight Junction Proteins 38%
• In Vitro Techniques 30%
• SB 3CT compound 19%
• Zonula Occludens-1 Protein 14%
• Occludin 12%
• Tight Junctions 11%
• Umbilicus 11%
• Proteasome Endopeptidase Complex 10%
• Matrix Metalloproteinases 9%
• Nervous System Diseases 9%
• Glioma 9%
• Permeability 8%
• Extracellular Matrix 8%
• Endothelial Cells 7%
• Maintenance 7%
• Down-Regulation 7%
• Messenger RNA 5%
• Brain 4%
• Proteins 3%
• Therapeutics 1%

Agriculture & Biology

• gelatinase A 100%
• blood-brain barrier 92%
• tight junctions 62%
• cells 22%
• proteins 16%
• nervous system diseases 13%
• umbilicus 13%
• glioma 13%
• proteasome endopeptidase complex 11%
• metalloproteinases 11%
• extracellular matrix 10%
• endothelial cells 10%
• risk factors 9%
• permeability 8%
• blood vessels 8%
• therapeutics 7%
• brain 6%
• degradation 6%
• rats 5%

Earth & Environmental Sciences

• brain 63%
• blood 55%
• cell 43%
• matrix 41%
• protein 31%
• damage 11%
• risk factor 8%
• regulation 6%
• permeability 5%
• degradation 5%
• loss 4%